Top compounds associated with response to CTNND2


Feature Type Standardized
Nominal ANOVA
mRNA ruxolitinib CTRPv2 pan-cancer AAC -0.014 0.7
mRNA MK-0752 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA ciclosporin CTRPv2 pan-cancer AAC -0.015 0.7
mRNA bafilomycin A1 CTRPv2 pan-cancer AAC 0.056 0.7
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC 0.032 0.7
mRNA chlorambucil CTRPv2 pan-cancer AAC 0.012 0.7
mRNA KH-CB19 CTRPv2 pan-cancer AAC 0.018 0.7
mRNA fulvestrant CTRPv2 pan-cancer AAC -0.036 0.7
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.02 0.7
mRNA BIBW2992 CTRPv2 pan-cancer AAC 0.014 0.7
Download CSV